Randomized, phase III, double-blind, vehicle-controlled clinical trial to evaluate the safety and efficacy of 12 weeks of twice-daily azelaic acid foam, 15% in papulopustular rosacea

被引:0
作者
Draelos, Zoe D. [1 ]
Elewski, Boni E. [2 ]
Harper, Julie C. [3 ]
Sand, Meike [4 ]
Staedtler, Gerald [4 ]
Nkulikiyinka, Richard [4 ]
Shakery, Kaweh [4 ]
机构
[1] Dermatol Consulting Serv, High Point, NC USA
[2] Univ Alabama Birmingham, Birmingham, AL USA
[3] Dermatol & Skin Care Ctr Birmingham PC, Birmingham, AL USA
[4] Bayer Healthcare, Global Dev, Berlin, Germany
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
850
引用
收藏
页码:AB59 / AB59
页数:1
相关论文
共 50 条
[41]   Efficacy and safety of Elagolix in endometriosis: Phase-III randomized double-blind active-controlled trial [J].
Gupta, N. ;
Palve, T. ;
Kamilya, G. ;
Srivastava, S. ;
Malathi, P. ;
Bohir, S. ;
Patel, J. S. ;
Dash, M. K. ;
Saigal, S. ;
Savalia, K. P. ;
Gupta, T. ;
Chaudhary, D. ;
Manohar, R. ;
Shah, P. ;
Bhat, V. V. ;
Shetty, A. ;
Saha, S. ;
Quadros, R. ;
Patil, D. ;
Patel, P. ;
Ghadge, P. ;
Mane, A. ;
Mehta, S. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2024, 131 :3-3
[42]   A multicenter randomized, vehicle-controlled, double-blind clinical study to examine the safety and efficacy of MAS063DP in the management of AD [J].
Abramovits, W ;
Hebert, A ;
Boguniewicz, M .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) :AB84-AB84
[43]   A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF CHIGLITAZAR IN NASH PATIENTS [J].
You, Hong ;
Sun, Yameng ;
Wu, Cuisong ;
Xin, Guijie ;
Zhong, Bihui ;
Wu, Xiaofeng ;
Liu, Yali ;
Shi, Junping ;
Zhang, Qin ;
Zhao, Yingren ;
Gao, Yufeng ;
Xin, Yongning ;
Zhu, Yueyong ;
Wu, Lixian ;
Mao, Xiaorong ;
Du, Jian ;
Shang, Jia ;
Sun, Weiwei ;
Xu, Jie ;
Yu, Zujiang ;
Nan, Yuemin ;
Sheng, Huiping ;
Li, Yue ;
Rao, Huiying ;
Yu, Chaohui ;
Wu, Xiaoning ;
Tong, Xiaofei .
HEPATOLOGY, 2024, 80 :S1969-S1970
[44]   A double-blind, placebo-controlled evaluation of safety and efficacy of 12-week, twice-daily treatment with prucalopride in patients with chronic constipation. [J].
Otten, MH ;
Schneider, H ;
Wurzer, H ;
Tefera, S ;
Van Eeghem, P ;
Graf, W ;
Van't Klooster .
GASTROENTEROLOGY, 1999, 116 (04) :A1055-A1055
[45]   The Bexagliflozin Efficacy and Safety Trial (BEST): A Randomized, Double-Blind, Placebo-Controlled, Phase IIII, Clinical Trial [J].
McMurray, John J. V. ;
Freeman, Mason W. ;
Massaro, Joe ;
Solomon, Scott ;
Lock, Paul ;
Riddle, Matthew C. ;
Halvorsen, Yuan-Di C. .
DIABETES, 2020, 69
[46]   A randomized, double-blind, vehicle-controlled phase 2b study of once-daily roflumilast foam 0.3% for scalp and body psoriasis [J].
Kircik, L. H. .
EXPERIMENTAL DERMATOLOGY, 2021, 30 :13-13
[47]   A Phase Iii Multi-Center, Randomized, Placebo-Controlled, Double-Blind Clinical Trial To Evaluate The Efficacy And Safety Of Desloratadine In Japanese Patients With Chronic Urticaria [J].
Hisada, S. ;
Imai, Y. ;
Oshima, N. ;
Tanaka, Y. ;
Weinstein, C. I. ;
Hide, M. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
[48]   Treatment of Multiple-Resistant and/or Recurrent Cutaneous Warts With Squaric Acid Dibutylester: A Randomized, Double-blind, Vehicle-controlled Clinical Trial [J].
Dall'Oglio, Federica ;
Luca, Maria ;
Barresi, Sebastiano ;
Micali, Giuseppe .
DERMATITIS, 2017, 28 (05) :308-312
[49]   A randomized, multicenter, double-blind, vehicle-controlled study evaluating the efficacy and safety of daily 2-week treatment with luliconazole in adults with tinea pedis [J].
Jarratt, Michael T. ;
Smith, Christina C. ;
Kaur, Mandeep ;
Pollak, Richard ;
Jones, Terry M. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) :AB107-AB107
[50]   Efficacy and safety of topical delgocitinib in patients with chronic hand eczema: data from a randomized, double-blind, vehicle-controlled phase IIa study [J].
Worm, M. ;
Bauer, A. ;
Elsner, P. ;
Mahler, V. ;
Molin, S. ;
Nielsen, T. S. S. .
BRITISH JOURNAL OF DERMATOLOGY, 2020, 182 (05) :1103-1110